| Dr Alfred T Shilling, MD | |
|
1906 Belleview Ave, Roanoke, VA 24014-1838 | |
| (540) 981-7000 | |
| (540) 981-8260 |
| Full Name | Dr Alfred T Shilling |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 21 Years |
| Location | 1906 Belleview Ave, Roanoke, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003029620 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Danbury Hospital | Danbury, CT | Hospital |
| Norwalk Hospital | Norwalk, CT | Hospital |
| Crouse Hospital | Syracuse, NY | Hospital |
| Fauquier Hospital | Warrenton, VA | Hospital |
| Oswego Hospital | Oswego, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Crouse Radiology Associates Llp | 1850387648 | 99 |
| Fauquier Physician Practices Llc | 6406083104 | 34 |
| Danbury Radiological Associates, Pc | 2264408533 | 35 |
| Premier Imaging Llc | 8820403637 | 32 |
News Archive
New research led by Professor Cathie Martin of the John Innes Centre has revealed how a plant used in traditional Chinese medicine produces compounds which may help to treat cancer and liver diseases.
China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it increased the size of its previously announced offering of convertible senior notes. On November 30, 2010, the Company priced US$125 million in aggregate principal amount of convertible senior notes due 2016 at an issue price of 100%. The transaction is expected to close on December 6, 2010, subject to satisfaction of various customary closing conditions.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 1000 mg.
The "skyrocketing rate" of immigrants to the U.S. who are held in detention centers "is the result of an administration policy decision" to detain "all those who may be subject to deportation" and has led to "serious concerns about its ability to provide adequate care to this growing population because of staff shortages and budget shortfalls that inevitably lead to neglect or errors," a Washington Post editorial states.
› Verified 6 days ago
| Entity Name | Carilion Healthcare Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447206370 PECOS PAC ID: 5890607253 Enrollment ID: O20031106000273 |
News Archive
New research led by Professor Cathie Martin of the John Innes Centre has revealed how a plant used in traditional Chinese medicine produces compounds which may help to treat cancer and liver diseases.
China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it increased the size of its previously announced offering of convertible senior notes. On November 30, 2010, the Company priced US$125 million in aggregate principal amount of convertible senior notes due 2016 at an issue price of 100%. The transaction is expected to close on December 6, 2010, subject to satisfaction of various customary closing conditions.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 1000 mg.
The "skyrocketing rate" of immigrants to the U.S. who are held in detention centers "is the result of an administration policy decision" to detain "all those who may be subject to deportation" and has led to "serious concerns about its ability to provide adequate care to this growing population because of staff shortages and budget shortfalls that inevitably lead to neglect or errors," a Washington Post editorial states.
› Verified 6 days ago
| Entity Name | University Of Virginia Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
New research led by Professor Cathie Martin of the John Innes Centre has revealed how a plant used in traditional Chinese medicine produces compounds which may help to treat cancer and liver diseases.
China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it increased the size of its previously announced offering of convertible senior notes. On November 30, 2010, the Company priced US$125 million in aggregate principal amount of convertible senior notes due 2016 at an issue price of 100%. The transaction is expected to close on December 6, 2010, subject to satisfaction of various customary closing conditions.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 1000 mg.
The "skyrocketing rate" of immigrants to the U.S. who are held in detention centers "is the result of an administration policy decision" to detain "all those who may be subject to deportation" and has led to "serious concerns about its ability to provide adequate care to this growing population because of staff shortages and budget shortfalls that inevitably lead to neglect or errors," a Washington Post editorial states.
› Verified 6 days ago
| Entity Name | Carilion Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730123472 PECOS PAC ID: 9830096585 Enrollment ID: O20040107000472 |
News Archive
New research led by Professor Cathie Martin of the John Innes Centre has revealed how a plant used in traditional Chinese medicine produces compounds which may help to treat cancer and liver diseases.
China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it increased the size of its previously announced offering of convertible senior notes. On November 30, 2010, the Company priced US$125 million in aggregate principal amount of convertible senior notes due 2016 at an issue price of 100%. The transaction is expected to close on December 6, 2010, subject to satisfaction of various customary closing conditions.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 1000 mg.
The "skyrocketing rate" of immigrants to the U.S. who are held in detention centers "is the result of an administration policy decision" to detain "all those who may be subject to deportation" and has led to "serious concerns about its ability to provide adequate care to this growing population because of staff shortages and budget shortfalls that inevitably lead to neglect or errors," a Washington Post editorial states.
› Verified 6 days ago
| Entity Name | Bath County Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417989278 PECOS PAC ID: 0840193819 Enrollment ID: O20040128000523 |
News Archive
New research led by Professor Cathie Martin of the John Innes Centre has revealed how a plant used in traditional Chinese medicine produces compounds which may help to treat cancer and liver diseases.
China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it increased the size of its previously announced offering of convertible senior notes. On November 30, 2010, the Company priced US$125 million in aggregate principal amount of convertible senior notes due 2016 at an issue price of 100%. The transaction is expected to close on December 6, 2010, subject to satisfaction of various customary closing conditions.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 1000 mg.
The "skyrocketing rate" of immigrants to the U.S. who are held in detention centers "is the result of an administration policy decision" to detain "all those who may be subject to deportation" and has led to "serious concerns about its ability to provide adequate care to this growing population because of staff shortages and budget shortfalls that inevitably lead to neglect or errors," a Washington Post editorial states.
› Verified 6 days ago
| Entity Name | Carilion Tazewell Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427040328 PECOS PAC ID: 4183604259 Enrollment ID: O20040721000540 |
News Archive
New research led by Professor Cathie Martin of the John Innes Centre has revealed how a plant used in traditional Chinese medicine produces compounds which may help to treat cancer and liver diseases.
China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it increased the size of its previously announced offering of convertible senior notes. On November 30, 2010, the Company priced US$125 million in aggregate principal amount of convertible senior notes due 2016 at an issue price of 100%. The transaction is expected to close on December 6, 2010, subject to satisfaction of various customary closing conditions.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 1000 mg.
The "skyrocketing rate" of immigrants to the U.S. who are held in detention centers "is the result of an administration policy decision" to detain "all those who may be subject to deportation" and has led to "serious concerns about its ability to provide adequate care to this growing population because of staff shortages and budget shortfalls that inevitably lead to neglect or errors," a Washington Post editorial states.
› Verified 6 days ago
| Entity Name | Carilion Rockbridge Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174636021 PECOS PAC ID: 4789658261 Enrollment ID: O20040820000838 |
News Archive
New research led by Professor Cathie Martin of the John Innes Centre has revealed how a plant used in traditional Chinese medicine produces compounds which may help to treat cancer and liver diseases.
China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it increased the size of its previously announced offering of convertible senior notes. On November 30, 2010, the Company priced US$125 million in aggregate principal amount of convertible senior notes due 2016 at an issue price of 100%. The transaction is expected to close on December 6, 2010, subject to satisfaction of various customary closing conditions.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 1000 mg.
The "skyrocketing rate" of immigrants to the U.S. who are held in detention centers "is the result of an administration policy decision" to detain "all those who may be subject to deportation" and has led to "serious concerns about its ability to provide adequate care to this growing population because of staff shortages and budget shortfalls that inevitably lead to neglect or errors," a Washington Post editorial states.
› Verified 6 days ago
| Entity Name | Hampton Roads Radiology Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174533624 PECOS PAC ID: 4880688506 Enrollment ID: O20041123000788 |
News Archive
New research led by Professor Cathie Martin of the John Innes Centre has revealed how a plant used in traditional Chinese medicine produces compounds which may help to treat cancer and liver diseases.
China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it increased the size of its previously announced offering of convertible senior notes. On November 30, 2010, the Company priced US$125 million in aggregate principal amount of convertible senior notes due 2016 at an issue price of 100%. The transaction is expected to close on December 6, 2010, subject to satisfaction of various customary closing conditions.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 1000 mg.
The "skyrocketing rate" of immigrants to the U.S. who are held in detention centers "is the result of an administration policy decision" to detain "all those who may be subject to deportation" and has led to "serious concerns about its ability to provide adequate care to this growing population because of staff shortages and budget shortfalls that inevitably lead to neglect or errors," a Washington Post editorial states.
› Verified 6 days ago
| Entity Name | Radiology Associates Of Roanoke, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962442293 PECOS PAC ID: 2365407574 Enrollment ID: O20041130000584 |
News Archive
New research led by Professor Cathie Martin of the John Innes Centre has revealed how a plant used in traditional Chinese medicine produces compounds which may help to treat cancer and liver diseases.
China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it increased the size of its previously announced offering of convertible senior notes. On November 30, 2010, the Company priced US$125 million in aggregate principal amount of convertible senior notes due 2016 at an issue price of 100%. The transaction is expected to close on December 6, 2010, subject to satisfaction of various customary closing conditions.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 1000 mg.
The "skyrocketing rate" of immigrants to the U.S. who are held in detention centers "is the result of an administration policy decision" to detain "all those who may be subject to deportation" and has led to "serious concerns about its ability to provide adequate care to this growing population because of staff shortages and budget shortfalls that inevitably lead to neglect or errors," a Washington Post editorial states.
› Verified 6 days ago
| Entity Name | Carilion Giles Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194718304 PECOS PAC ID: 3678670221 Enrollment ID: O20070516000487 |
News Archive
New research led by Professor Cathie Martin of the John Innes Centre has revealed how a plant used in traditional Chinese medicine produces compounds which may help to treat cancer and liver diseases.
China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it increased the size of its previously announced offering of convertible senior notes. On November 30, 2010, the Company priced US$125 million in aggregate principal amount of convertible senior notes due 2016 at an issue price of 100%. The transaction is expected to close on December 6, 2010, subject to satisfaction of various customary closing conditions.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 1000 mg.
The "skyrocketing rate" of immigrants to the U.S. who are held in detention centers "is the result of an administration policy decision" to detain "all those who may be subject to deportation" and has led to "serious concerns about its ability to provide adequate care to this growing population because of staff shortages and budget shortfalls that inevitably lead to neglect or errors," a Washington Post editorial states.
› Verified 6 days ago
| Entity Name | University Of Virginia Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720233596 PECOS PAC ID: 2567479405 Enrollment ID: O20090421000339 |
News Archive
New research led by Professor Cathie Martin of the John Innes Centre has revealed how a plant used in traditional Chinese medicine produces compounds which may help to treat cancer and liver diseases.
China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it increased the size of its previously announced offering of convertible senior notes. On November 30, 2010, the Company priced US$125 million in aggregate principal amount of convertible senior notes due 2016 at an issue price of 100%. The transaction is expected to close on December 6, 2010, subject to satisfaction of various customary closing conditions.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 1000 mg.
The "skyrocketing rate" of immigrants to the U.S. who are held in detention centers "is the result of an administration policy decision" to detain "all those who may be subject to deportation" and has led to "serious concerns about its ability to provide adequate care to this growing population because of staff shortages and budget shortfalls that inevitably lead to neglect or errors," a Washington Post editorial states.
› Verified 6 days ago
| Entity Name | Fauquier Physician Practices Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770916983 PECOS PAC ID: 6406083104 Enrollment ID: O20131227001299 |
News Archive
New research led by Professor Cathie Martin of the John Innes Centre has revealed how a plant used in traditional Chinese medicine produces compounds which may help to treat cancer and liver diseases.
China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it increased the size of its previously announced offering of convertible senior notes. On November 30, 2010, the Company priced US$125 million in aggregate principal amount of convertible senior notes due 2016 at an issue price of 100%. The transaction is expected to close on December 6, 2010, subject to satisfaction of various customary closing conditions.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 1000 mg.
The "skyrocketing rate" of immigrants to the U.S. who are held in detention centers "is the result of an administration policy decision" to detain "all those who may be subject to deportation" and has led to "serious concerns about its ability to provide adequate care to this growing population because of staff shortages and budget shortfalls that inevitably lead to neglect or errors," a Washington Post editorial states.
› Verified 6 days ago
| Entity Name | Crouse Radiology Associates Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447244587 PECOS PAC ID: 1850387648 Enrollment ID: O20230601003149 |
News Archive
New research led by Professor Cathie Martin of the John Innes Centre has revealed how a plant used in traditional Chinese medicine produces compounds which may help to treat cancer and liver diseases.
China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it increased the size of its previously announced offering of convertible senior notes. On November 30, 2010, the Company priced US$125 million in aggregate principal amount of convertible senior notes due 2016 at an issue price of 100%. The transaction is expected to close on December 6, 2010, subject to satisfaction of various customary closing conditions.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 1000 mg.
The "skyrocketing rate" of immigrants to the U.S. who are held in detention centers "is the result of an administration policy decision" to detain "all those who may be subject to deportation" and has led to "serious concerns about its ability to provide adequate care to this growing population because of staff shortages and budget shortfalls that inevitably lead to neglect or errors," a Washington Post editorial states.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alfred T Shilling, MD 213 S Jefferson St Ste 625, Roanoke, VA 24011-1713 Ph: (540) 224-5374 | Dr Alfred T Shilling, MD 1906 Belleview Ave, Roanoke, VA 24014-1838 Ph: (540) 981-7000 |
News Archive
New research led by Professor Cathie Martin of the John Innes Centre has revealed how a plant used in traditional Chinese medicine produces compounds which may help to treat cancer and liver diseases.
China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it increased the size of its previously announced offering of convertible senior notes. On November 30, 2010, the Company priced US$125 million in aggregate principal amount of convertible senior notes due 2016 at an issue price of 100%. The transaction is expected to close on December 6, 2010, subject to satisfaction of various customary closing conditions.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 1000 mg.
The "skyrocketing rate" of immigrants to the U.S. who are held in detention centers "is the result of an administration policy decision" to detain "all those who may be subject to deportation" and has led to "serious concerns about its ability to provide adequate care to this growing population because of staff shortages and budget shortfalls that inevitably lead to neglect or errors," a Washington Post editorial states.
› Verified 6 days ago
Ronald L Washburn, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 1906 Belleview Ave Se, Roanoke, VA 24014 Phone: 540-981-7000 Fax: 540-342-1757 | |
Gary L Aragon, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 213 S Jefferson St Ste 1006, Roanoke, VA 24011 Phone: 540-224-5715 | |
Dr. Vishal Mukesh Patel, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1906 Belleview Ave Se, Roanoke, VA 24014 Phone: 352-642-3783 | |
Michael S Chung, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1906 Belleview Ave Se, Roanoke, VA 24014 Phone: 540-981-7083 | |
Dr. Bert Cody Piggott Jr., M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1906 Belleview Ave Se, Roanoke, VA 24014 Phone: 540-981-7000 Fax: 540-342-1757 | |
Francine Lee Jacobson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1906 Belleview Ave Se, Roanoke, VA 24014 Phone: 540-981-7083 Fax: 540-981-8260 |